Viewing Study NCT02322866


Ignite Creation Date: 2025-12-24 @ 4:20 PM
Ignite Modification Date: 2026-01-27 @ 4:49 AM
Study NCT ID: NCT02322866
Status: COMPLETED
Last Update Posted: 2019-02-01
First Post: 2014-12-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne
Sponsor: Almirall, S.A.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SC1402
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View